shutterstock_607718810

ABOUT

IMMUNO CURE

Immuno Cure is a biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-based DNA vaccine and Anti-PD-1 Isoform Antibody technology platforms.

Learn More

OUR

TEAM

More Detail
Dr. Percy Cheng

Dr. Percy CHENG 

MH 
(Co-Founder)

Executive Director
Chairman of the Board

Andy Wong

Mr. Andy WONG

(Co-Founder)

Executive Director

Chief Executive Officer

Peter Tang

Mr. Peter TANG

(Co-Founder)

Executive Director

Dr. Leong

Dr. Che Hung LEONG, Edward

GBM, GBS, OBE, JP

Chairman of Advisory Board

Dr. Ko

Dr. Wing Man KO

GBS, JP

Advisory Board Member

Dr. David Ho

Dr. Da I HO, David

Advisory Board Member

Prof Chen

Prof. Zhiwei CHEN

(Co-Founder)

Advisory Board Member

and Principal Scientific Advisor

Mark Lo

Mr. Mark LO

Chief Financial Officer

Mr. Tom Lau

Mr. Tom LAU

(Co-Founder)

Director of Corporate Finance

Dr. Wai Sing Fai

Dr. Sing Fai WAI

Chief Technology Officer

Michael Wong

Dr. Michael WONG

Research and Development Director

David Du

Mr. Yanhua DU, David

General Manager of

Shenzhen Immuno Cure

Wang Ting

Ms. Ting WANG

Clinical and Regulatory Director

PD-1-BASED

DNA VACCINE PLATFORM

Learn More

PD-1 ISOFORM

BLOCKADE PLATFORM

Learn More
pipeline-photo

PIPELINE

Learn More